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Abstract
Ricinine (3-cyano-4-methoxy-N-methyl-2-pyridone) is a urinary biomarker which can be 
measured to confirm human exposure to castor bean products such as ricin. As many consumer 
products contain castor oil, another castor bean product, ricinine may be detectable in the general 
population. The following study characterized urinary ricinine concentrations from 989 
individuals who were presumed to be unexposed to ricin. An automated diagnostic method was 
utilized here to simplify the analysis of this large sample set. Sample preparation included a 96-
well polystyrene divinylbenzene high throughput extraction and preconcentration step. Purified 
samples were analyzed by an efficient dual column, reversed phase liquid chromatography 
separation and 13C-isotope dilution tandem mass spectrometry. In this convenience sample, only 
1.2% of the urine samples had detectable amounts of ricinine randomly distributed between 0.186 
and 4.15 ng/mL.
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Introduction
The castor bean plant, Ricinus communis, is the only known source of the toxin ricin (1). It 
is also the source of castor oil which is harvested to produce many beneficial products such 
as lubricants, pharmaceuticals, cosmetics, paints, and plastics (2; 3). Although an extremely 
potent protein toxin that is lethal to humans (4; 5; 6) and animals (7; 8; 9), ricin has also 
been investigated for use in the treatment of cancer (10; 11; 12) and AIDS (13; 10; 11). 
Active ricin is not present in castor oil as it is insoluble in oil (1), and the toxin is 
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deactivated if the extraction is carried out under heated conditions such as those found in 
castor oil production (14). The small alkaloid ricinine (165 Da) is another component 
present in the castor bean and has been found in both ricin preparations and in castor oil 
(15). Detection of urine ricinine has been used as a biomarker of castor bean product 
exposure and has been used to confirm castor bean ingestion in suicide attempts (16).
Despite the many legitimate uses of the castor bean, ricin is an attractive toxin for terrorists 
(17). This is primarily due to the wide availability of the castor bean plant, the ease of toxin 
extraction from the seeds, and the high toxicity of the protein toxin. Castor seeds are 
harvested in Asia, Central and South America, Africa, and Europe with global castor bean 
production exceeding 1 million metric tons per year (http://faostat.fao.org/site/567/
DesktopDefault.aspx?PageID=567#ancor accessed 03/02/2012; http://www.crnindia.com/
commodity/castor.html accessed 03/02/2012) (15). Since ricin accounts for approximately 
1–5% of the weight of the seed, there is the potential to produce 10,000 metric tons of ricin 
as a manufacturing by-product.
Inhalation and injection are the most potent means of ricin poisoning with estimated lethal 
doses ranging from 0.01 mg/kg to 1 mg/kg (15). The most common cause of ricin poisoning 
is ingestion of castor seeds despite being the least potent route of exposure (14). Intact castor 
seeds can pass through the digestive tract with minimal symptoms, and the level of seed 
mastication and maceration has a strong correlation with the observed toxicity of the 
ingested seeds (18, 16).
Ricin is an approximately 65 kDa glycoprotein (19; 20), and detection of the intact toxin 
using liquid chromatography tandem mass spectrometry (LC-MS/MS) without first 
performing a protein digest is not practical (21; 22; 23; 24). The small molecule ricinine (3-
cyano-4-methoxy-N-methyl-2-pyridone) (Figure 1) has proven useful as a urinary biomarker 
for castor bean product exposure since it can be found in ricin preparations and is readily 
excreted after intoxication by ricin extracts. Ricinine (LD50 340 mg/kg i.p. in mice and 3 
g/kg i.g. in mice) (25) can be measured non-invasively in urine via automated solid phase 
extraction (SPE) followed by LC-MS/MS analysis (15). Ricinine is unique to Ricinus 
communis, so its presence implies an exposure to a product derived from castor seeds which 
may include extracted ricin.
When the ricinine assay was first developed, only 30 individual specimens were analyzed in 
which no ricinine was detected (15). However, it was expected that ricinine concentrations 
should be detectable in some people since it was known that ricinine is present in consumer 
products that utilize castor oil. A follow-on expanded analysis was needed, and a group of 
989 samples was selected for testing. The number of samples selected was based on a 
combination of factors including the laboratory’s expanded capability to process samples 
quickly in a high throughput format and the fact that a large set of samples were readily 
available in house for testing. The results of the analysis of these urine samples and a brief 
description of the diagnostic method are presented in this paper.
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Native ricinine standards in urine (calibrators: 0.300, 0.500, 10.0, 30.0, 100, 150 ng/mL; QC 
standards: 1.00 and 50.0 ng/mL) were purchased from Cerilliant Corporation (Round Rock, 
TX) and stored at −70°C until needed. An additional calibrator, 0.0800 ng/mL, was prepared 
by dilution of the 0.500 ng/mL calibrator using DI water to use for bracketing unknowns 
with measured values below the normal 0.300 ng/mL calibration standard. Isotopically 
labeled ricinine (13C6) in water (11.0 ng/mL) and blank urine was also purchased from 
Cerilliant and stored at −70°C. These solutions are not available to the general public, but 
can be reproduced by following previously published methodologies (15). Human urine 
samples were purchased from Tennessee Blood Services (Memphis, TN). This study used 
urine acquired from commercial sources and thus the work did not meet the definition of 
human subjects as specified in 45 CFR 46.102 (f). Each sample was stored at −70°C. HPLC-
grade methanol, acetonitrile, and water were purchased from Tedia (Fairfield, OH). Fluka 
LC-MS grade formic acid was purchased from Sigma-Aldrich (St. Louis, MO).
Sample preparation
All reference and unknown urine samples were aliquoted into 2 mL Nunc polypropylene 
round bottom 96-well microplates from Thermo Fisher Scientific (Rochester, NY). Internal 
standard was added manually following aliquoting into the 96-well plate. Manual addition of 
internal standard was needed to reduce waste when plates were not completely occupied 
with reference or unknown urine samples. Solutions were manipulated using 20–300 µL 
single- and/or multi-channel micropipettes from Rainin (Oakland, CA), the Formatter 
Sample Processing Workstation from Tomtec (Hamden, CT), and the Sciclone i1000 Liquid 
Handling Workstation from Caliper Life Sciences (Hopkinton, MA). Solutions were mixed 
prior to aliquoting with a laboratory vortexer from Fisher Scientific (Pittsburgh, PA).
Each 96-well plate contained 200 µL aliquots of the following: four spiked urine samples 
randomly added to the plate to ensure that LC-MS/MS results matched the predicted plate 
pattern; aliquots of each calibrator, blank and quality control standard; and up to 74 random 
unknown urine samples. This plating process was repeated for all 989 unknown urine 
samples. Each 96-well plate of unknowns, calibrators, and QC standards was considered an 
analytical batch.
Thirty microliters of 13C6-isotopically enriched internal standard solution was added to each 
well, and the plate was mixed using a Labsystems Wellmix 96-well microplate mixer from 
Thermo Scientific (Waltham, MA). The plate was then transferred to the Caliper i1000 for 
vacuum extraction using a Strata-X, 33 µm polymeric reversed phase 60 mg/well 96-well 
SPE microplate from Phenomenex (Torrence, CA). The sorbent bed was conditioned with 
1150 µL of methanol followed by 1150 µL of HPLC grade water. Then, 150 µL of each 
reference or unknown urine sample were loaded onto the sorbent bed. The sorbent bed was 
then washed using 1150 µL of 5% methanol in water. Finally, 800 µL of acetonitrile was 
used to elute the retained portion of the samples into 2 mL Nunc microplates.
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The extracted samples were dried in the collection plates under nitrogen at 60°C using a 
Biotage (Charlotte, NC) TurboVap 96 Concentration Evaporator Workstation. Dried 
samples were reconstituted by adding 100 µL of HPLC grade water with the Caliper i1000 
and vortexing the plate for one minute. Extracts were then transferred to an Advion PCR 
microplate, and the plate was sealed with a Thermo Scientific (Waltham, MA) Easy Pierce 
20 µm foil heat seal (PN AB-1720).
Instrumental Analysis
An Agilent Technologies (Santa Clara, CA) 1200 HPLC (two G1312A binary pumps, two 
G1379B degassers, one G1367B well-plate autosampler, and one G1316A column heating 
compartment equipped with an internal 10-port switching valve) was used for 
chromatographic separations. Twenty microliters of extract was injected onto 2×100-mm 
Polar RP Phenyl columns (Synergi, 2.5 µm, 100Ǻ) from Phenomenex (Torrence, CA) with a 
300 µL/min flow rate and 40°C column temperature. Two columns were utilized in parallel 
with one acting as the analytical column for the mass spectrometer while the other was being 
re-equilibrated. The two mobile phases were (A) 10% methanol in water with 0.019% 
formic acid, and (B) acetonitrile with 0.019% formic acid. The starting mobile phase 
concentration was 7% B. After 0.5 min, a gradient ramp to 50% B was initiated, ending at 
2.0 min. These conditions were then held for one minute before returning to the original 
starting conditions for three minutes of re-equilibration (total LC run time is six minutes). At 
this point the 10-port valve was used to switch to the other column to initiate the next run.
An AB Sciex (Foster City, CA) API 4000 QTRAP triple-quadrupole mass spectrometer 
equipped with a turbo-ion-spray source was interfaced to the HPLC and operated in 
positive-ion multiple-reaction-monitoring (MRM) mode. The precursor/product ion 
transitions that were monitored were m/z 165/138 (quantitation), m/z 165/82 (confirmation), 
and m/z 171/144 (internal standard). Data analysis was performed using Analyst 1.4.2 
instrument control software (AB Sciex, Foster City, CA). A 1/x-weighted linear least 
squares regression was applied to the standard concentration versus the area ratio of the 
quantification ion to the internal standard ion. A correlation coefficient (r2) of 0.990 or 
greater was used as a criterion for quantitation. A typical chromatogram for the lowest 
calibration standard is presented in Figure 2. The area ratio of the quantitation ion to the 
confirmation ion (i.e. confirmation ratio) was used as a criterion for specificity. The 
confirmation ratios for the calibrators in each analytical batch were averaged and a tolerance 
of +/−30% was applied to confirm all positive samples. An analytical batch consisted of 1 
blank, 6 calibrators, 2 quality control (QC) materials, and any unknowns included on the 
microplate.
Results and Discussion
The purpose of this study was to measure urinary ricinine concentrations from a large 
convenience sample group. To accomplish this, 989 individual specimens were extracted 
and analyzed for ricinine using an established method from this laboratory (15). The number 
of samples analyzed was based on the ability to process samples quickly, and that these 
samples were readily available for testing.
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To ensure high quality results in this high throughput testing method, the following standard 
protocols were added to those of the manual method: 1) should one of the QC samples 
within a batch fail evaluation, the entire batch (96-well plate) including calibrators and 
unknown samples associated with that QC were re-aliquoted, re-extracted and rerun; 2) any 
sample with a positive result for ricinine was re-extracted and rerun to confirm the results; 3) 
if a sample did not have a minimum internal standard response of 1.0×104 area counts, the 
sample was re-extracted and rerun.
To increase the throughput of analyzing this large set of unknown samples, two automated 
sample handling instruments were utilized in series. Each instrument was calibrated 
spectrophotometrically, with a NIST traceable reference, prior to use to ensure pipetting 
accuracy. Each instrument also contained at least one automated liquid sensing device to 
ensure each sample was processed correctly. Approximately 200 samples (three 96-well 
microplates) could be aliquoted in one day using the Tomtec Formatter. Those same samples 
could then be immediately extracted using the Caliper i1000 liquid handler and analyzed by 
the API 4000 Q-trap LC-MS/MS. This automation allowed the analyst to perform the solid 
phase extraction on one set of samples while simultaneously aliquoting another set.
Of the individual specimens analyzed, 1.2% contained detectable amounts of ricinine. 
Concentrations ranged from 0.186 to 4.15 ng/mL (see Table 1) with a method detection limit 
of 0.080 ng/mL. All samples that initially were positive for ricinine were rerun using an 
added calibrator at the method limit of detection. The lowest calibrator was selected to 
appropriately bracket two results which were observed below the lowest commercially 
produced calibrator. All positive results fell within the expected concentration range of 
ricinine 48 h after a lethal exposure to ricin (0.08 – 10 ng/mL) which assumes minimal ricin 
extraction (15). However, because ricinine is a separate alkaloid that is present in 
pharmaceutical and cosmetic products that contain castor oil constituents, and these results 
are within the expected range of a lethal exposure to ricin, the presence of ricinine as a 
marker for castor bean or ricin exposure needs to be interpreted in the context of other 
exposures in addition to whether it is consistent with the clinical presentation of a ricin 
exposure.
Conclusion
Nine Hundred eighty-nine individual human urine specimens were analyzed by LC-MS/MS, 
and 12 of those samples (1.2%) were found to contain detectable amounts of ricinine. Health 
care professionals charged with evaluating a positive result for this assay should take into 
consideration the context of any positive ricinine results such as patient symptoms, patient 
exposure to unknown white powders, and patient use of castor oil or castor oil derived 
consumer products. Also, because analysis of these individual specimens found positive 
results not found in a smaller sample set, larger background analyses should be considered 
for any compound that, like ricinine, could reasonably be expected to be found in urine 
samples of the general population. A well designed automation process made such an 
expanded analysis a reasonable undertaking.
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Structure of Ricinine - Internal standard 13C-labeling indicated by an asterisk
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Typical Chromatogram of Ricinine: quantitation and confirmation transitions for 0.3 ng/mL 
standard (t0 = 0.68 min, k’ = 4.33)
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